Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Moxydak-CV 625 Tablet

Prescription Icon
Prescription Required

Marketer

Dakgaur Healthcare

Salt Composition

Amoxycillin (500mg) + Clavulanic Acid (125mg)

Overview Moxydak-CV 625 Tablet

Avelox 625mg tablets are antibacterial medication combating bacterial infections. They effectively treat lung infections (pneumonia, for instance), ear, sinus, urinary tract, skin, and soft tissue infections. However, they are ineffective against viral illnesses like the common cold. For optimal stomach comfort, take Avelox 625mg with food, adhering strictly to your doctor's prescribed schedule for consistent dosing. Complete the full course of antibiotics, as directed, even if symptoms improve. Premature cessation can allow bacterial resurgence and infection worsening. Common side effects, typically mild, include nausea, diarrhea, vomiting, oral or genital yeast infections, skin rashes, and vaginal inflammation. Report any persistent or bothersome side effects to your physician. Prior to use, disclose any antibiotic allergies, kidney or liver conditions, and all other medications you're taking to your doctor, as interactions are possible. Generally, this medication is safe for pregnant and breastfeeding individuals under medical supervision.

Uses of Moxydak-CV 625 Tablet

Combating Bacterial Infections

Major Benefits of Moxydak-CV 625 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Moxydak-CV 625 Tablet whole; do not crush, chew, or fracture it. Administer this medication with a meal.

Common Side effects of Moxydak-CV 625 Tablet:

  • Vaginal inflammation
  • Mucocutaneous candidiasis
  • Vomiting
  • Nausea
  • Diarrhea
  • Skin rash
  • Red spots or bumps
  • Fungal infection

How to use Moxydak-CV 625 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Moxydak-CV 625 Tablets should be administered with a meal.

How Moxydak-CV 625 Tablet works:

Moxydak-CV 625 tablets contain amoxicillin, a bacterial growth inhibitor, and clavulanic acid, a beta-lactamase inhibitor. Amoxicillin's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to reproduce. The addition of clavulanic acid counteracts bacterial resistance mechanisms, thereby improving amoxicillin's effectiveness.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Moxydak-CV 625 Tablet and alcohol consumption.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Moxydak-CV 625 Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

During breastfeeding, Moxydak-CV 625 Tablet is considered safe. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects of Moxydak-CV 625 Tablets, including allergic reactions, dizziness, or seizures.

KidneyKidneyCAUTION

Amoxicillin/clavulanate 625 mg tablets require careful administration in individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Moxydak-CV 625 Tablets. Dosage modification may be necessary. Physician consultation is advised. Routine liver function assessments are recommended during treatment.

What if you forget to take Moxydak-CV 625 Tablet :

Should you forget a Moxydak-CV 625 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Moxydak-CV 625 Tablet

LabelValue
Developing Habits No.
Treatment Category Infectious Disease Treatments

FAQs on Moxydak-CV 625 Tablet

Moxydak-CV 625 tablets combine amoxicillin and clavulanic acid to combat bacterial infections. These infections may include tonsillitis, sinusitis, otitis media, respiratory and urinary tract infections, boils, abscesses, cellulitis, wound and bone infections, and oral cavity infections. The medication's mechanism involves eliminating harmful bacteria.
Moxydak-CV 625 Tablet is safe when used as directed by your physician. However, some patients may experience side effects such as diarrhea, nausea, vomiting, rash, or allergic reactions, along with other less frequent side effects. Report any persistent issues to your doctor immediately.
Moxydak-CV 625 Tablets are contraindicated in patients with penicillin allergies or allergies to any of its components, and should not be taken by those with liver disease. Always inform your doctor of any medication allergies.
Moxydak-CV 625 Tablets may reduce the effectiveness of birth control pills. Discuss alternative contraceptive methods, such as condoms, diaphragms, or spermicides, with your doctor while using this medication.
Exceeding the recommended Moxydak-CV 625 Tablet dosage raises the risk of side effects. This medication requires time for full effectiveness and infection resolution. Contact your doctor if symptoms worsen.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Don't discontinue Moxydak-CV 625 Tablet prematurely. Even if you feel better, complete the entire course. Symptom improvement doesn't guarantee complete infection resolution; the medication continues to work even when you feel better.
Moxydak-CV 625 Tablets can trigger allergic reactions and should be avoided by individuals with penicillin allergies. Seek immediate medical attention if you experience symptoms such as hives, breathing difficulties, or facial, lip, tongue, or throat swelling.
Moxydak-CV 625 Tablets can cause diarrhea, a side effect from its action of killing harmful bacteria. This antibiotic may also affect beneficial gut bacteria, leading to diarrhea. If diarrhea occurs, increase fluid intake. Consult your doctor if diarrhea persists or you experience dehydration symptoms such as reduced urination and dark, strong-smelling urine. Do not self-medicate.
Moxydak-CV 625 Tablets are ineffective against viral infections such as colds and the flu. Seek medical advice; do not self-medicate.
Moxydak-CV 625 Tablets do not cause drowsiness. Report any drowsiness to your doctor.
Moxydak-CV 625 Tablet
139